Aigen Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,608
Closed -$416K 710
2025
Q3
$416K Buy
+7,608
New +$380K 0.06% 445
2024
Q1
Sell
-21,836
Closed -$1.62M 770
2023
Q4
$1.62M Buy
21,836
+9,080
+71% +$595K 0.29% 89
2023
Q3
$870K Buy
+12,756
New +$1.08M 0.16% 198
2023
Q2
Sell
-16,043
Closed -$1.09M 816
2023
Q1
$1.09M Buy
+16,043
New +$1.03M 0.15% 171

Other funds holding EXAS

Aigen Investment Management's EXAS Position: Q4 2025 in Review

Aigen Investment Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 7,608 shares — an estimated $416K sold.

Aigen Investment Management first reported a position in EXAS in Q1 2023 and held it in 4 quarters. The position peaked at $1.62M in Q4 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Aigen Investment Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 7,608 Exact Sciences shares in Q4 2025, an estimated $416K.
  • Aigen Investment Management first reported a position in Exact Sciences in Q1 2023 and held it in 4 quarters.
  • Aigen Investment Management's Exact Sciences position peaked at $1.62M in Q4 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.